Finanzwire Finanzwire
Basculer en Français
10884 Companies
236852 Keywords
165737 Articles
127075 Press releases
Headlines Articles Press releases UCB Remove
  1. Home
  2. Companies
  3. UCB
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/08/2025 at 07:45, 8 months 18 days ago

    UCB Reports Positive Phase 3 Trial Results for Fenfluramine in CDKL5 Disorder

    UCB Phase 3 Study Fenfluramine CDKL5 Deficiency Seizure Reduction
  • PRESS RELEASE

    published on 12/08/2025 at 07:40, 8 months 18 days ago

    UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

    UCB presents positive results from GEMZ phase 3 study at AES showing significant reduction in countable motor seizure frequency in CDKL5 Deficiency Disorder. Study demonstrates efficacy and safety of fenfluramine as adjunctive treatment
    AES UCB Fenfluramine Seizure Reduction GEMZ Phase 3 Study
    Logo of UCB
Accesswire
  • Published on 08/26/2026 at 15:00, 12 minutes ago

    Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

  • Published on 08/26/2026 at 15:00, 12 minutes ago

    Arcus Announces Voting Results of the Annual General and Special Meeting

  • Published on 08/26/2026 at 14:30, 42 minutes ago

    Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update

  • Published on 08/26/2026 at 14:30, 42 minutes ago

    NV Gold Announces Commencement of 2026 Drill Program at its Slumber Gold Project

  • Published on 08/26/2026 at 14:17, 55 minutes ago

    Worksport (NASDAQ: WKSP) Posts Record $2.5M July Orders; Seven-Month Consecutive Sales Climb Continues; $30M ARR

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 15:07, 4 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 08/26/2026 at 15:07, 5 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

  • Published on 08/26/2026 at 15:06, 5 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

  • Published on 08/26/2026 at 15:05, 6 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Rotork plc

  • Published on 08/26/2026 at 15:05, 7 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS
Les Echos
  • Published on 08/25/2026 at 17:45, 21 hours 27 minutes ago

    CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 08/25/2026 at 17:45, 21 hours 27 minutes ago

    Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026

  • Published on 08/25/2026 at 08:30, 1 day 6 hours ago

    Eiffage wins several contracts worth a total of €132 million in the healthcare sector

  • Published on 08/24/2026 at 18:00, 1 day 21 hours ago

    Outstanding shares and voting rights statement at 31 July 2026

  • Published on 08/24/2026 at 17:59, 1 day 21 hours ago

    Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy